insights_auto
Why is EYPT down 3.08%?
Dive Deeperchevron_right
EYPT:NASDAQ
EyePoint Inc
$3.15
arrow_downward
-3.08%(-0.100) 1D
$3.15
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 5, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
$3.28
High
$3.28
Low
$3.05
Mkt. cap
271.57M
Avg. vol.
3.81M
Volume
2.76M
52-wk high
$19.01
52-wk low
$3.05
EPS
-$3.74
Beta
1.67
Shares outstanding
86.21M
No. of employees
214
Open
$3.28
High
$3.28
Low
$3.05
Mkt. cap
271.57M
Avg. vol.
3.81M
Volume
2.76M
52-wk high
$19.01
52-wk low
$3.05
EPS
-$3.74
Beta
1.67
Shares outstanding
86.21M
No. of employees
214
News stories
From web sources and news partners
AD HOC NEWS
·
1 day ago
EyePoint Pharmaceuticals stock holds at USD 3.25 after loss
CNBC
·
1 month ago
Stocks making the biggest moves midday: EyePoint, Intuitive Machines, Workday, JetBlue & more
Investor's Business Daily
·
1 month ago
The Surprising Reason This Biotech Just Plummeted 67%
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersWatertown, Massachusetts, United States
SectorPharmaceutical industry
Websiteeyepoint.bio